Recital 17, Regulation (EC) No 1610/96 of the European Parliament and of the Council of 23 July 1996…

In forcecited 4×

Whereas the detailed rules in recitals 12, 13 and 14 and in Articles 3 (2), 4, 8 (1) (c) and 17 (2) of this Regulation are also valid, mutatis mutandis, for the interpretation in particular of recital 9 and Articles 3, 4, 8 (1) (c) and 17 of Council Regulation (EEC) No 1768/92,

  • Judgment of the Court (Fifth Chamber) of 16 September 1999. Farmitalia Carlo Erba Srl.Decision

    Moreover, it should be borne in mind that the 13th recital in the preamble to Regulation (EC) 1610/96 of the European Parliament and of the Council of 23 July 1996 which, by virtue of the 17th recital, is also valid, mutatis mutandis, for …

    16 Sep 1999 · 61997CJ0392

  • Judgment of the Court (Third Chamber) of 3 September 2009. AHP Manufacturing BV v Bureau voor de Industriële Eigendom.Decision

    That statement by the Court corresponds to the provisions of Regulation No 1610/96 which, although it was adopted before the date of delivery of the Biogen judgment, entered into force after that date. The second sentence of Article 3(2) …

    3 Sep 2009 · 62007CJ0482

  • Judgment of the Court (Second Chamber) of 20 December 2017. Incyte Corporation v Szellemi Tulajdon Nemzeti Hivatala.Decisioninterprets

    As regards the relevance of Article 17(2) of Regulation No 1610/96 to a situation, such as that at issue in the main proceedings, in which the SPC was granted for a medicinal product rather than a plant-protection product, it should be …

    20 Dec 2017 · 62016CJ0492

  • Opinion of Advocate General Saugmandsgaard Øe delivered on 13 December 2018. Abraxis Bioscience LLC v Comptroller General of Patents.Decision

    It is, in my opinion, from that perspective that it is necessary to understand recital 14 of Regulation No 1610/96, which Abraxis relies upon in order to establish the validity of the scope of protection of the basic patent test. That …

    13 Dec 2018 · 62017CC0443